M. Gadelha, F. Gatto, L.E. Wildemberg, M. Fleseriu, Cushing’s syndrome. Lancet. 402(10418), 2237–2252 (2023)
F. Fallo, Di G. Dalmazi, F. Beuschlein, N.R. Biermasz, F. Castinetti, A. Elenkova et al., Diagnosis and management of hypertension in patients with cushing’s syndrome: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension. J. Hypertens. 40(11), 2085–2101 (2022)
L.K. Nieman, B.M.K. Biller, J.W. Findling, M.H. Murad, J. Newell-Price, M.O. Savage et al., Treatment of cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100(8), 2807–2831 (2015)
Article PubMed PubMed Central Google Scholar
M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev et al., Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur. J. Endocrinol. 175(2), G1–G34 (2016)
L.K. Nieman, B.M.K. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart et al., The diagnosis of cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008)
Article PubMed PubMed Central Google Scholar
M. Balomenaki, D. Margaritopoulos, D.A. Vassiliadi, S. Tsagarakis, Diagnostic workup of cushing’s syndrome. J. Neuroendocrinol. 34(8), e13111 (2022)
M. Fassnacht, S. Tsagarakis, M. Terzolo, A. Tabarin, A. Sahdev, J. Newell-Price et al., European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur. J. Endocrinol. 189(1), G1–G42 (2023)
A. Vaidya, A. Hamrahian, I. Bancos, M. Fleseriu, H.K. Ghayee, THE EVALUATION OF INCIDENTALLY DISCOVERED ADRENAL MASSES. Endocr. Pract. 25(2), 178–192 (2019)
F. Ceccato, C. Artusi, M. Barbot, L. Lizzul, S. Pinelli, G. Costantini et al., Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation. J. Endocrinol. Invest. 43(8), 1105–1113 (2020)
N. Vogg, M. Kurlbaum, T. Deutschbein, B. Gräsl, M. Fassnacht, M. Kroiss, Method-Specific cortisol and dexamethasone thresholds increase clinical specificity of the dexamethasone suppression test for Cushing syndrome. Clin. Chem. 67(7), 998–1007 (2021)
G. Ueland, P. Methlie, R. Kellmann, M. Bjørgaas, B.O. Åsvold, K. Thorstensen et al., Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. Eur. J. Endocrinol. 176(6), 705–713 (2017)
K. Chen, S. Chen, L. Lu, H. Zhu, X. Zhang, A. Tong et al., An optimized pathway for the differential diagnosis of ACTH-Dependent cushing’s syndrome based on Low-Dose dexamethasone suppression test. Front. Endocrinol. (Lausanne). 12, 720823 (2021)
A. Kumar, J. Kanwar, N. Bharti, V. Agrawal, E. Bhatia, S.C. Yadav, Low diagnostic utility of overnight High-Dose dexamethasone suppression test in ACTH-Dependent cushing’s syndrome. Endocr. Pract. 27(7), 723–727 (2021)
S. Agbana, M. McIlroy, Extra-nuclear and cytoplasmic steroid receptor signalling in hormone dependent cancers. J. Steroid Biochem. Mol. Biol. 243, 106559 (2024)
L. Vierbaum, N. Weiss, P. Kaiser, M. Kremser, F. Wenzel, M. Thevis et al., Longitudinal analysis of external quality assessment of immunoassay-based steroid hormone measurement indicates potential for improvement in standardization. Front. Mol. Biosci. 11, 1345356 (2024)
Article PubMed PubMed Central Google Scholar
H. Frederiksen, T.H. Johannsen, S.E. Andersen, J.H. Petersen, A.S. Busch, M.L. Ljubicic et al., Sex- and age-specific reference intervals of 16 steroid metabolites quantified simultaneously by LC-MS/MS in Sera from 2458 healthy subjects aged 0 to 77 years. Clin. Chim. Acta. 562, 119852 (2024)
D. Mu, X. Qian, Y. Ma, X. Wang, Y. Gao, X. Ma et al., Plasma steroid profiling combined with machine learning for the differential diagnosis in mild autonomous cortisol secretion from nonfunctioning adenoma in patients with adrenal incidentalomas. Endocr. Pract. 30(7), 647–656 (2024)
J. Noh, C. Lee, J.H. Kim, S.W. Myung, M.H. Choi, LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines. J. Lipid Res. 64(11), 100453 (2023)
Article PubMed PubMed Central Google Scholar
C. Gao, L. Ding, X. Zhang, M. Yuan, S. Tang, W. Li et al., Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease. Front. Endocrinol. (Lausanne). 14, 1158573 (2023)
H. Dong, B. Hu, W. Chen, L. Wang, H. Sun, J. Zhou et al., A LC-MS/MS method for the simultaneous quantitative determination of aldosterone, its precursor 18-hydroxycorticosterone and its metabolite tetrahydroaldosterone in human urine. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 1234, 124012 (2024)
S. Yu, Y. Yin, Y. Zou, Q. Li, J. Yu, S. Xie et al., A comprehensive LC-MS/MS method for the simultaneous measurement of 24 adrenal steroids: from research to clinical practice. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 1232, 123941 (2024)
G. Eisenhofer, J. Masjkur, M. Peitzsch, Di G. Dalmazi, M. Bidlingmaier, M. Grüber et al., Plasma steroid metabolome profiling for diagnosis and subtyping patients with Cushing syndrome. Clin. Chem. 64(3), 586–596 (2018)
L.T. Braun, A. Osswald, S. Zopp, G. Rubinstein, F. Vogel, A. Riester et al., Delineating endogenous cushing’s syndrome by GC-MS urinary steroid metabotyping. EBioMedicine. 99, 104907 (2024)
N. Genere, R.J. Kaur, S. Athimulam, M.A. Thomas, T. Nippoldt, Van M. Norman et al., Interpretation of abnormal dexamethasone suppression test is enhanced with use of synchronous free cortisol assessment. J. Clin. Endocrinol. Metab. 107(3), e1221–e30 (2022)
C. Melau, B. Gayete Mor, M. Lundgaard Riis, J.E. Nielsen, E. Dreisler, K. Aaboe et al., Dexamethasone affects human fetal adrenal steroidogenesis and subsequent ACTH response in an ex vivo culture model. Front. Endocrinol. (Lausanne). 14, 1114211 (2023)
P.M. Stewart, Tissue-specific cushing’s syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur. J. Endocrinol. 149(3), 163–168 (2003)
S. Athimulam, S. Grebe, I. Bancos, Steroid profiling in the diagnosis of mild and overt cushing’s syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 35(1), 101488 (2021)
Article PubMed PubMed Central Google Scholar
R. Knuchel, Z. Erlic, S. Gruber, L. Amar, C.K. Larsen, A.-P. Gimenez-Roqueplo et al., Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension. Front. Endocrinol. (Lausanne). 15, 1370525 (2024)
H. Nakao, M. Yokomoto-Umakoshi, K. Nakatani, H. Umakoshi, M. Ogata, T. Fukumoto et al., Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism. EBioMedicine. 95, 104733 (2023)
Article PubMed PubMed Central Google Scholar
C.H. Ahn, C. Lee, J. Shim, S.H. Kong, S.-J. Kim, Y.H. Kim et al., Metabolic changes in serum steroids for diagnosing and subtyping cushing’s syndrome. J. Steroid Biochem. Mol. Biol. 210, 105856 (2021)
B.G. Issa, F.W.F. Hanna, A.A. Fryer, G. Ensah, I. Ebere, D. Marshall et al., The utility of salivary cortisone in the overnight dexamethasone suppression test in adrenal incidentalomas. J. Clin. Endocrinol. Metab. 108(10), e937–e43 (2023)
M. Mordaunt, A. Heald, W. Majeed, R. Kochhar, A. Syed, R.N. Mudaliar et al., Morning salivary cortisone versus serum cortisol in the overnight dexamethasone suppression test (ODNST): evaluation in a clinical setting. Clin. Endocrinol. (Oxf). 103(1), 13–20 (2025)
A. Prete, I. Bancos, Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches. Nat. Rev. Endocrinol. 20(8), 460–473 (2024)
Comments (0)